Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
141.1 USD | +0.06% | -1.45% | +12.03% |
May. 02 | Earnings Flash (ASND) ASCENDIS PHARMA Reports Q1 Revenue EUR95.9M | MT |
Apr. 29 | European Equities Traded in the US as American Depositary Receipts Nudge Higher in Monday Trading | MT |
Business Summary
Number of employees: 879
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100.0
%
| 54 | 100.0 % | 288 | 100.0 % | +436.15% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
North America
71.9
%
| 46 | 86.3 % | 207 | 71.9 % | +346.54% |
Asia
27.8
%
| 7 | 12.6 % | 80 | 27.8 % | +1,080.01% |
Europe
0.3
%
| 1 | 1.1 % | 1 | 0.3 % | +61.94% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jan Mikkelsen
FOU | Founder | 65 | 06-08-31 |
Scott Smith
DFI | Director of Finance/CFO | 50 | 16-08-07 |
Stina Singel
CTO | Chief Tech/Sci/R&D Officer | 50 | 20-04-30 |
Kennett Sprogøe
CTO | Chief Tech/Sci/R&D Officer | 46 | 07-11-30 |
Chief Administrative Officer | 62 | 07-11-30 | |
Peter Rasmussen
AUD | Comptroller/Controller/Auditor | 55 | 14-02-28 |
Corporate Officer/Principal | 63 | 15-07-31 | |
General Counsel | 53 | 07-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jan Mikkelsen
FOU | Founder | 65 | 06-08-31 |
Albert Cha
CHM | Chairman | 51 | 14-10-31 |
General Counsel | 53 | 07-12-31 | |
Lisa Bright
BRD | Director/Board Member | 56 | 17-03-31 |
Lars Holtug
BRD | Director/Board Member | 66 | 18-11-01 |
William Fairey
BRD | Director/Board Member | 59 | 22-08-31 |
Siham Imani
BRD | Director/Board Member | 47 | 22-08-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 57,707,439 | 6,000,000 ( 10.40 %) | 0 | 10.40 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.03% | 8.06B | |
-1.65% | 104B | |
+6.75% | 97.47B | |
+5.71% | 22.25B | |
-12.60% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.17% | 16.36B | |
+6.12% | 14.39B | |
+35.47% | 12.37B |
- Stock Market
- Equities
- ASND Stock
- Company Ascendis Pharma A/S